Literature DB >> 9729037

Individual variations in the murine T cell response to a specific peptide reflect variability in naive repertoires.

P Bousso1, A Casrouge, J D Altman, M Haury, J Kanellopoulos, J P Abastado, P Kourilsky.   

Abstract

Previous studies have analyzed the diversity of T cell responses upon immunization. Little is known, however, about the individual variability of naive repertoires and its influence on immune responses. In the present study, T cells specific for a Kd-restricted epitope derived from HLA-A2 were purified from individual immunized mice using tetramers of MHC-peptide. Their TCRbeta chains were sequenced revealing strong biases but large variations in BJ usage and clonal composition. Most importantly, sequence analysis from nonimmunized mice demonstrated the preexistence of a small set of splenic precursors, distinct in each mouse and comprising less than 200 cells. Therefore, differences in precursor pools appear to be the major source of individual variability in antigen-selected repertoires.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9729037     DOI: 10.1016/s1074-7613(00)80599-3

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  54 in total

Review 1.  New methods for assessing T-cell responses.

Authors:  N Bercovici; M T Duffour; S Agrawal; M Salcedo; J P Abastado
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

2.  Comparative T cell receptor repertoire selection by antigen after adoptive transfer: a glimpse at an antigen-specific preimmune repertoire.

Authors:  V Attuil; P Bucher; M Rossi; M Mutin; J L Maryanski
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

Review 3.  Determinants of public T cell responses.

Authors:  Hanjie Li; Congting Ye; Guoli Ji; Jiahuai Han
Journal:  Cell Res       Date:  2012-01-03       Impact factor: 25.617

4.  Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease.

Authors:  Hemalatha Rangarajan; Maryam Yassai; Hariharan Subramanian; Richard Komorowski; Megan Whitaker; Jack Gorski; William R Drobyski
Journal:  Blood       Date:  2012-04-10       Impact factor: 22.113

5.  Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion.

Authors:  Nicole L La Gruta; William T Rothwell; Tania Cukalac; Natasha G Swan; Sophie A Valkenburg; Katherine Kedzierska; Paul G Thomas; Peter C Doherty; Stephen J Turner
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

Review 6.  Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model system.

Authors:  Jason Botten; John Sidney; Bianca R Mothé; Bjoern Peters; Alessandro Sette; Maya F Kotturi
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

7.  Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection.

Authors:  Vladimir P Badovinac; Jodie S Haring; John T Harty
Journal:  Immunity       Date:  2007-06-07       Impact factor: 31.745

8.  Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude.

Authors:  James J Moon; H Hamlet Chu; Marion Pepper; Stephen J McSorley; Stephen C Jameson; Ross M Kedl; Marc K Jenkins
Journal:  Immunity       Date:  2007-08-16       Impact factor: 31.745

9.  Broad cross-reactive TCR repertoires recognizing dissimilar Epstein-Barr and influenza A virus epitopes.

Authors:  Shalyn C Clute; Yuri N Naumov; Levi B Watkin; Nuray Aslan; John L Sullivan; David A Thorley-Lawson; Katherine Luzuriaga; Raymond M Welsh; Roberto Puzone; Franco Celada; Liisa K Selin
Journal:  J Immunol       Date:  2010-11-03       Impact factor: 5.422

10.  Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection.

Authors:  Joshua J Obar; Kamal M Khanna; Leo Lefrançois
Journal:  Immunity       Date:  2008-05-22       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.